Immune Checkpoint Assays

Immune checkpoints represent a group of membrane proteins expressed on effector cells (e.g., T/B cells and NK cells) that are composed of a variety of co-inhibitory and co-stimulatory pathways. They are involved in eliminating unwanted substances while maintaining their own tolerance, which plays a crucial role in immune regulation.

Generally, there are two types of immune checkpoints: activating receptors and inhibitory receptors. Thus, the two main mechanisms of immunotherapeutic antibodies can be defined as blocking the pathway (antagonists) and enhancing the pathway (agonists). To thoroughly validate the mechanism of action of these antibodies, Creative Biolabs has combined a range of cell-based assays with our state-of-the-art technology and in-depth knowledge in the field to provide a full range of immune checkpoints assay approaches for antibody functional characterization.

Immune Checkpoint Targets (including but not limited to):

Inhibitory Immune Checkpoints T cells are attacking cancer cells Stimulatory Immune Checkpoints
Target Receptor
B7-1(CD80) PD-L1
B7-2(CD86) CTLA4
PD-L1 PD-1
PD-L2 B7-1&PD-1
CD48 CD244
CD155 TIGIT
CD112 CD112R
KIR MHC I
NKGD2 RAE-1
Target Receptor
MHC TCR
B7-H2 ICOS
CD137L CD137
OX40L OX40
GITRL GITR
CD70 CD27
CD40 CD40L
Mechanism of Immune Checkpoint Assays

Details of Our Checkpoint Assays

  • ■ Immunological checkpoint blocking assays from multiple classical pathways, readings by FACS or ELISA
  • ■ Custom cell-based, reporter or receptor-ligand assay
  • ■ Induce biologically relevant responses without the use of difficult and expensive primary cells (reporter cell lines)
  • ■ T cell proliferation assay, cytokine production assay, and T cell cytotoxicity assay
  • ■ All tests are performed using high quality reagents and strictly controlled by experienced immunologists

We can help our clients design a roadmap that begins with the screening and analysis of the selected candidates, performs interaction analysis with the selected candidates, and then progresses to the analysis of the immunomodulatory function. Through this roadmap, we can demonstrate the binding and functional properties of antibodies and their underlying mechanisms of action.

For more details, please feel free to contact us or send us a query directly.

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2024 Creative Biolabs. All Rights Reserved.